Why the study?
Does stentless mitral valve replacement provide adequate hemodynamic function in patients requiring mitral valve replacement?
Does stentless mitral valve replacement provide adequate hemodynamic function in patients requiring mitral valve replacement?
Stentless mitral valve replacement demonstrates promising and stable hemodynamic function up to 3 years postoperatively.
Answers are grounded in this paper and cite their sources.
Stable hemodynamics to 3 years may support stentless mitral replacement in select patients; leaves open need for randomized trials on durability and outcomes.
The purpose of this study was to evaluate the perioperative and postoperative hemodynamic function of recently introduced stentless mitral valves (SMVs). Forty-two selected patients who had received the SMV since 1997 had preoperative, postoperative, and follow-up transthoracic echocardiographic (TTE) examinations. Transesophageal echocardiography (TEE) was applied routinely during the operation as well as postoperatively if indicated. Adequate SMV function was seen in all patients perioperatively. Echocardiographic prediction of valve size and of papillary muscle distances was correct in 37 of 42 patients. Transvalvular blood flow velocities were 1.6 +/- 0.2 m/s postoperatively versus 1.8 +/- 0.3 m/s at 1 year and 1.7 +/- 0.3 m/s at 3-year follow-up. Mean transvalvular gradients were 4.3 +/- 1.6, 3.8 +/- 1.9, and 4.7 +/- 1.1 mm Hg, respectively. TEE and TTE are extremely useful to assist SMV implantation as well as for regular follow-up evaluation. The hemodynamic function after SMV implantation with preservation of the annulo-ventricular continuity is promising.
No takes yet. Share an insight, caveat, or question.
Walther et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: